A pilot proteomic study of amyloid precursor interactors in Alzheimer's disease

Annals of Neurology

Volumn 58, Issue 2, 2005, Pages 277-289

  Cottrell, Barbara A ^a,f   Galvan, Veronica ^a   Banwait, Surita ^a   Gorostiza, Olivia ^a   Lombardo, Christian R ^b   Williams, Tristan ^c   Schilling, Birgit ^a   Peel, Alyson ^a   Gibson, Bradford ^a   Koo, Edward H ^d   Link, Christopher D ^e   Bredesen, Dale E ^a,g  

^a BUCK INSTITUTE FOR RESEARCH ON AGING   (United States)

^b CELGENE CORPORATION   (United States)

^c BURNHAM INSTITUTE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF COLORADO   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; AMYLOID PRECURSOR PROTEIN; BETA ACTIN; BETA TUBULIN; CHAPERONE; CRYSTALLIN; CYCLOPHILIN A; CYTOSKELETON PROTEIN; DYNAMIN; DYNEIN ADENOSINE TRIPHOSPHATASE; FODRIN; GLIAL FIBRILLARY ACIDIC PROTEIN; HEAT SHOCK PROTEIN 90; MYOSIN; NEUROFILAMENT PROTEIN; PHOSPHOGLYCERATE MUTASE; PROTEIN FE65; STRUCTURAL PROTEIN; SYNTAXIN; UBIQUITIN THIOLESTERASE; URACIL DNA GLYCOSYLTRANSFERASE;

ALZHEIMER DISEASE; ARTICLE; CAENORHABDITIS ELEGANS; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; IMMUNOPRECIPITATION; MASS SPECTROMETRY; NERVE FIBER TRANSPORT; PILOT STUDY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FOLDING; PROTEOMICS; WESTERN BLOTTING;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; BLOTTING, WESTERN; BRAIN; CRYSTALLINS; DYNAMINS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; NERVE TISSUE PROTEINS; PILOT PROJECTS; PROTEOMICS;

EID: 23244456099     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.20554     Document Type: Article

References (65)

1. Mattson MP. Addendum: pathways towards and away from Alzheimer's disease. Nature 2004;431:107.
2. National Institute of Mental Health. Clinical trials: Alzheimer's disease and related disorders. Vol. 2005: Washington, DC: U.S. Department of Health and Human Services, 2005.
3. The Alzheimer's Disease Education and Referral (ADEAR) Center. National Institute on Aging progress report on Alzheimer's disease. Vol. 1998. Silver Spring, MD: U.S. Department of Health and Human Services, National Institutes of Health, National Institute on Aging, 1998.
4. Selkoe DJ. Alzheimer's disease is a synaptic failure. Science 2002;298:789-791.
5. Nunan J, Small DH. Proteolytic processing of the amyloid-beta protein precursor of Alzheimer's disease. Essays Biochem 2002; 38:37-49.
6. Lu DC, Rabizadeh S, Chandra S, et al. A second cytotoxic proteolytic peptide derived from amyloid beta-protein precursor. Nat Med 2000;6:397-404.
7. Galvan V, Chen S, Lu D, et al. Caspase cleavage of members of the amyloid precursor family of proteins. J Neurochem 2002; 82:283-294.
8. Pellegrini L, Passer BJ, Tabaton M, et al. Alternative, non-secretase processing of Alzheimer's beta-amyloid precursor protein during apoptosis by caspase-6 and -8. J Biol Chem 1999; 274:21011-21016.
9. Weidemann A, Paliga K, Durrwang U, et al. Proteolytic processing of the Alzheimer's disease amyloid precursor protein within its cytoplasmic domain by caspase-like proteases. J Biol Chem 1999;274:5823-5829.
10. Buxbaum JD, Thinakaran G, Koliatsos V, et al. Alzheimer amyloid protein precursor in the rat hippocampus: transport and processing through the perforant path. J Neurosci 1998;18: 9629-9637.
11. Gunawardena S, Goldstein LS. Disruption of axonal transport and neuronal viability by amyloid precursor protein mutations in Drosophila. Neuron 2001;32:389-401.
12. Kamal A, Almenar-Queralt A, LeBlanc JF, et al. Kinesin-mediated axonal transport of a membrane compartment containing beta-secretase and presenilin-1 requires APP. Nature 2001;414:643-648.
13. Sabo SL, Ikin AF, Buxbaum JD, Greengard P. The amyloid precursor protein and its regulatory protein, FE65, in growth cones and synapses in vitro and in vivo. J Neurosci 2003;23: 5407-5415.
14. Sabo SL, Ikin AF, Buxbaum JD, Greengard P. The Alzheimer amyloid precursor protein (APP) and FE65, an APP-binding protein, regulate cell movement. J Cell Biol 2001;153: 1403-1414.
15. Kamenetz F, Tomita T, Hsieh H, et al. APP processing and synaptic function. Neuron 2003;37:925-937.
16. Taru H, Iijima K, Hase M, et al. Interaction of Alzheimer's beta-amyloid precursor family proteins with scaffold proteins of the JNK signaling cascade. J Biol Chem 2002;277: 20070-20078.
17. Scheinfeld MH, Roncarati R, Vito P, et al. Jun NH2-terminal kinase (JNK) interacting protein 1 (JIP1) binds the cytoplasmic domain of the Alzheimer's beta-amyloid precursor protein (APP). J Biol Chem 2002;277:3767-3775.
18. Homayouni R, Rice DS, Sheldon M, Curran T. Disabled-1 binds to the cytoplasmic domain of amyloid precursor-like protein 1. J Neurosci 1999;19:7507-7515.
19. Matsuda S, Yasukawa T, Homma Y, et al. c-Jun N-terminal kinase (JNK)-interacting protein-1b/islet-brain-I scaffolds Alzheimer's amyloid precursor protein with JNK. J Neurosci 2001; 21:6597-6607.
20. Fiore F, Zamhrano N, Minopoli G, et al. The regions of the Fe65 protein homologous to the phosphotyrosine interaction/ phosphotyrosine binding domain of Shc bind the intracellular domain of the Alzheimer's amyloid precursor protein. J Biol Chem 1995;270:30853-30856.
21. Zambrano N, Buxbaum JD, Minopoli G, et al. Interaction of the phosphotyrosine interaction/phosphotyrosine binding-related domains of Fe65 with wild-type and mutant Alzheimer's beta-amyloid precursor proteins. J Biol Chem 1997;272: 6399-6405.
22. McLoughlin DM, Miller CC. The intracellular cytoplasmic domain of the Alzheimer's disease amyloid precursor protein interacts with phosphotyrosine-binding domain proteins in the yeast two-hybrid system. FEBS Lett 1996;397:197-200.
23. Biederer T, Cao X, Sudhof TC, Liu X. Regulation of APP-dependent transcription complexes by Mint/X11s: differential functions of Mint isororms. J Neurosci 2002;22:7340-7351.
24. Schonberger SJ, Edgar PF, Kydd R, et al. Proteomic analysis of the brain in Alzheimer's disease: molecular phenotype of a complex disease process. Proteomics 2001;1:1519-1528.
25. Tsuji T, Shimohama S. Analysis of the proteomic profiling of brain tissue in Alzheimer's disease. Dis Markers 2001;17: 247-257.
26. Yoo BC, Kim SH, Cairns N, et al. Deranged expression of molecular chaperones in brains of patients with Alzheimer's disease. Biochem Biophys Res Commun 2001;280:249-258.
27. Castegna A, Aksenov M, Aksenova M, et al. Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part 1: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1. Free Radic Biol Med 2002;33:562-571.
28. Nakamura Y, Takeda M, Niigawa H, et al. Amyloid beta-protein precursor deposition in rat hippocampus lesioned by ibotenic acid injection. Neurosci Lett 1992;136:95-98.
29. Sisodia SS, Koo EH, Hoffman PN, et al. Identification and transport of full-length amyloid precursor proteins in rat peripheral nervous system. J Neurosci 1993;13:3136-3142.
30. Perkins DN, Pappin DJ, Creasy DM, Cottrell JS. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 1999;20: 3551-3567.
31. Baek SH, Ohgi KA, Rose DW, et al. Exchange of N-CoR corepressor and Tip60 coactivator complexes links gene expression by NF-kappaB and beta-amyloid precursor protein. Cell 2002; 110:55-67.
32. Cao X, Sudhof TC. A transcriptionally [correction of transcriptively] active complex of APP with Fe65 and histone acetyltransferase Tip60. Science 2001;293:115-120.
33. Kimberly WT, Zheng JB, Guenette SY, Selkoe DJ. The intracellular domain of the beta-amyloid precursor protein is stabilized by Fe65 and translocates to the nucleus in a notch-like manner. J Biol Chem 2001;276:40288-40292.
34. Umahara T, Uchihara T, Tsuchiya K, et al. 14-3-3 proteins and zeta isoform containing neurofibrillary tangles in patients with Alzheimer's disease. Acta Neuropathol (Berl) 2004;108: 279-286.
35. Hernandez F, Cuadros R, Avila J. Zeta 14-3-3 protein favours the formation of human tau fibrillar polymers. Neurosci Lett 2004;357:143-146.
36. Hashiguchi M, Sobue K, Paudel HK. 14-3-3zeta is an effector of tau protein phosphorylation. J Biol Chem 2000;275: 25247-25254.
37. Choe LH, Green A, Knight RS, et al. Apolipoprotein E and other cerebrospinal fluid proteins differentiate ante mortem variant Creutzfeldt-Jakob disease from ante mortem sporadic Creutzfeldt-Jakob disease. Electrophoresis 2002;23:2242-2246.
38. Stege GJ, Renkawek K, Overkamp PS, et al. The molecular chaperone alphaB-crystallin enhances amyloid beta neurotoxicity. Biochem Biophys Res Commun 1999;262:152-156.
39. Liang JJ. Interaction between beta-amyloid and lens alphaB-crystallin. FEBS Lett 2000;484:98-101.
40. Fonte V, Kapulkin V, Taft A, et al. Interaction of intracellular beta amyloid peptide with chaperone proteins. Proc Natl Acad Sci U S A 2002;99:9439-9444.
41. Link CD, Taft A, Kapulkin V, et al. Gene expression analysis in a transgenic Caenorhabditis elegans Alzheimer's disease model. Neurobiol Aging 2003;24:397-413.
42. Hsia AY, Masliah E, McConlogue L, et al. Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. Proc Natl Acad Sci U S A 1999;96:3228-3233.
43. Mucke L, Masliah E, Yu GQ, et al. High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J Neurosci 2000;20:4050-4058.
44. Costes SV, Daelemans D, Cho EH, et al. Automatic and quantitative measurement of protein-protein colocalization in live cells. Biophys J 2004;86:3993-4003.
45. Chyung JH, Selkoe DJ. Inhibition of receptor-mediated endocytosis demonstrates generation of amyloid beta-protein at the cell surface. J Biol Chem 2003;278:51035-51043.
46. Ehehalt R, Keller P, Haass C, et al. Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts. J Cell Biol 2003;160:113-123.
47. Parkin ET, Turner AJ, Hooper NM. Amyloid precursor protein, although partially detergent-insoluble in mouse cerebral cortex, behaves as an atypical lipid raft protein. Biochem J 1999;344(pt 1):23-30.
48. Tun H, Marlow L, Pinnix I, et al. Lipid rafts play an important role in A beta biogenesis by regulating the beta-secretase pathway. J Mol Neurosci 2002;19:31-35.
49. Bridgman PC. Myosin-dependent transport in neurons. J Neurobiol 2004;58:164-174.
50. Shea TB, Flanagan LA. Kinesin, dynein and neurofilament transport. Trends Neurosci 2001;24:644-648.
51. Ho CS, Marinescu V, Steinhilb ML, et al. Synergistic effects of Munc18a and X11 proteins on amyloid precursor protein metabolism. J Biol Chem 2002;277:27021-27028.
52. Tsai MY, Morfini G, Szebenyi G, Brady ST. Release of kinesin from vesicles by hsc70 and regulation of fast axonal transport. Mol Biol Cell 2000;11:2161-2173.
53. Shupliakov O, Bloom O, Gustafsson JS, et al. Impaired recycling of synaptic vesicles after acute perturbation of the presynaptic actin cytoskeleton. Proc Natl Acad Sci U S A 2002;99: 14476-14481.
54. Van Der Hoeven PC, Van Der Wal JC, Ruurs P, et al. 14-3-3 isotypes facilitate coupling of protein kinase C-zeta to Raf-1: negative regulation by 14-3-3 phosphorylation. Biochem J 2000;345(pt 2):297-306.
55. Fountoulakis M, Cairns N, Lubec G. Increased levels of 14-3-3 gamma and epsilon proteins in brain of patients with Alzheimer's disease and Down syndrome. J Neural Transm Suppl 1999;57:323-335.
56. Denker SP, Barber DL. Ion transport proteins anchor and regulate the cytoskeleton. Curr Opin Cell Biol 2002;14:214-220.
57. Lopez-Schier H, St Johnston D. Drosophila nicastrin is essential for the intramembranous cleavage of notch. Dev Cell 2002;2: 79-89.
58. Johnson RJ, Xiao G, Shanmugaratnam J, Fine RE. Calreticulin functions as a molecular chaperone for the beta-amyloid precursor protein. Neurobiol Aging 2001;22:387-395.
59. Yang Y, Turner RS, Gaut JR. The chaperone BiP/GRP78 binds to amyloid precursor protein and decreases Abeta40 and Abeta42 secretion. J Biol Chem 1998;273:25552-25555.
60. Chiesi M, Longoni S, Limbruno U. Cardiac alpha-crystallin. III. Involvement during heart ischemia. Mol Cell Biochem 1990;97:129-136.
61. Hatters DM, Lindner RA, Carver JA, Howlett GJ. The molecular chaperone, alpha-crystallin, inhibits amyloid formation by apolipoprotein C-II. J Biol Chem 2001;276:33755-33761.
62. Ito H, Kamei K, Iwamoto I, et al. Inhibition of proteasomes induces accumulation, phosphorylation, and recruitment of HSP27 and alphaB-crystallin to aggresomes. J Biochem (Tokyo) 2002;131:593-603.
63. Kouchi Z, Sorimachi H, Suzuki K, Ishiura S. Proteasome inhibitors induce the association of Alzheimer's amyloid precursor protein with Hsc7.3. Biochem Biophys Res Commun 1999;254: 804-810.
64. Song S, Kim SY, Hong YM, et al. Essential role of E2-25K/ Hip-2 in mediating amyloid-beta neurotoxicity. Mol Cell 2003; 12:553-563.
65. Nishitoh H, Matsuzawa A, Tobiume K, et al. ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats. Genes Dev 2002;16:1345-1355.